Multigroup study and clinical application of key molecules in the pathogenesis of inflammatory bowel disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036115

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

CD patients group:Nil

UC patients group:Nil

healthy controls group-1:NIl

IBD surgical patients group:Nil

healthy controls group-2:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for inflammatory bowel disease; 2. Aged over 18 year.

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical data; 2. Without definite clinical diagnosis; 3. Combined with colon cancer, intestinal tuberculosis, infectious enteritis and other intestinal diseases or other diseases affecting the intestines outside the intestine.

Design outcomes

Primary

Measure	Time frame
genomics;proteomics;	—

Countries

China

Contacts

Public ContactZhanju Liu

Shanghai Tenth People's Hospital

liuzhanju88@126.com+86 18917683431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026